Marimed (MRMD) Notes Payables (2016 - 2025)
Historic Notes Payables for Marimed (MRMD) over the last 12 years, with Q3 2025 value amounting to $2.3 million.
- Marimed's Notes Payables fell 4685.43% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 4685.43%. This contributed to the annual value of $5.1 million for FY2024, which is 60899.03% up from last year.
- Per Marimed's latest filing, its Notes Payables stood at $2.3 million for Q3 2025, which was down 4685.43% from $3.4 million recorded in Q2 2025.
- Marimed's Notes Payables' 5-year high stood at $5.1 million during Q4 2024, with a 5-year trough of $4856.0 in Q1 2021.
- Over the past 5 years, Marimed's median Notes Payables value was $1.1 million (recorded in 2024), while the average stood at $1.8 million.
- As far as peak fluctuations go, Marimed's Notes Payables plummeted by 9997.62% in 2021, and later skyrocketed by 249798.66% in 2024.
- Marimed's Notes Payables (Quarter) stood at $1.4 million in 2021, then surged by 167.66% to $3.8 million in 2022, then plummeted by 80.84% to $723000.0 in 2023, then soared by 608.99% to $5.1 million in 2024, then plummeted by 54.68% to $2.3 million in 2025.
- Its last three reported values are $2.3 million in Q3 2025, $3.4 million for Q2 2025, and $4.8 million during Q1 2025.